IMM 20.3% 35.5¢ immutep limited

future price target, page-3

  1. 2,214 Posts.
    chil020 - there is nothing wrong with using the DNDN journey to date as a yardstick for PRR. With one big difference; DNDN highlighted one big potential problem with their slip up over doctor's reimbursements, that PRR can now avoid.

    So PRR beinga multi-billion, multi-dollar stock is still a reality. And don't forget PRR has more than one billion dollar product potentially in it's bag.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.